GemPharmatech Co., Ltd.

GemPharmatech is a leading global contract research organization (CRO) specializing in the development and supply of genetically engineered mouse models (GEMMs) for the biomedical research and pharmaceutical industry. The company maintains one of the world's largest collections of mouse strains, including knockout/conditional knockout, humanized, immunodeficient, and germ-free models. Beyond model generation, GemPharmatech provides comprehensive preclinical services, including custom model creation, CRISPR/Cas9 gene editing, cryopreservation, and in vivo pharmacology studies such as drug efficacy evaluation and phenotyping. With a strong focus on R&D, the company supports researchers worldwide in drug target discovery, disease mechanism analysis, and therapeutic development.